These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6771143)

  • 1. On the mechanism of action of 4'-[(9-acridinyl)-amino] methanesulphon-m-anisidide.
    Ralph RK
    Eur J Cancer (1965); 1980 May; 16(5):595-600. PubMed ID: 6771143
    [No Abstract]   [Full Text] [Related]  

  • 2. A reassessment of the mechanism of action of 4'-[(9-acridinyl)-amino]methanesulphon-m-anisidide.
    Marshall B; Ralph RK
    Eur J Cancer Clin Oncol; 1982 Jun; 18(6):553-7. PubMed ID: 6811280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nature of DNA breakage by 4'-[(9-acridinyl)amino]methane-sulphone-m-anisidide.
    Marshall B; Ralph RK
    FEBS Lett; 1982 Aug; 145(2):187-90. PubMed ID: 6290268
    [No Abstract]   [Full Text] [Related]  

  • 4. Blocked 5'-termini in the fragments of chromosomal DNA produced in cells exposed to the antitumor drug 4'-[(9-acridinyl)-amino]methanesulphon-m-anisidide (mAMSA).
    Marshall B; Ralph RK; Hancock R
    Nucleic Acids Res; 1983 Jun; 11(12):4251-6. PubMed ID: 6306581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that mAMSA induces topoisomerase action.
    Marshall B; Darkin S; Ralph RK
    FEBS Lett; 1983 Sep; 161(1):75-8. PubMed ID: 6309576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of 4'-(9-acridinylamino)methanesulphon-m-anisidine) action by verapamil.
    Darkin S; Ralph RK
    Cancer Lett; 1986 Jan; 30(1):25-33. PubMed ID: 3080225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport of AMSA drugs into cells.
    Darkin S; Ralph RK
    FEBS Lett; 1985 Oct; 190(2):349-53. PubMed ID: 3930297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of the intercalating agent 4'-(9-acridylamino)-methanesulphon-m -anisidide to induce DNA-repair replication in cultured human cells.
    Wilkins RJ
    Mutat Res; 1983 Nov; 122(2):211-6. PubMed ID: 6689200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-cycle-stage specificity of 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and interaction with ionizing radiation in mammalian cell cultures.
    Wilson WR; Whitmore GF
    Radiat Res; 1981 Jul; 87(1):121-36. PubMed ID: 7019954
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitumour activity of substituted 9-anilinoacridines--comparison of in vivo and in vitro testing systems.
    Baguley BC; Nash R
    Eur J Cancer (1965); 1981 Jun; 17(6):671-9. PubMed ID: 6895501
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative and qualitative effects of m-AMSA (amsacrine) on cellular immune components.
    Miller T; Bleumink N
    Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1307-16. PubMed ID: 6386483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m-AMSA: a new anticancer agent.
    Rozencweig M; Von Hoff DD; Legha SS; Cysyk RL; Muggia FM
    Recent Results Cancer Res; 1980; 74():250-7. PubMed ID: 6893753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprotection by 9-aminoacridine derivatives against the cytotoxicity of topoisomerase II-directed drugs.
    Finlay GJ; Wilson WR; Baguley BC
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1695-701. PubMed ID: 2561099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the DNA intercalators 4'-(9-acridinylamino)methanesulfon-m-anisidide and 2-methyl-9-hydroxyellipticinium on topoisomerase II mediated DNA strand cleavage and strand passage.
    Pommier Y; Minford JK; Schwartz RE; Zwelling LA; Kohn KW
    Biochemistry; 1985 Nov; 24(23):6410-6. PubMed ID: 3002440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the topoisomerase II-mediated DNA scission produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide in L1210 murine leukemia cells.
    Zwelling LA; Kerrigan D; Marton LJ
    Cancer Res; 1985 Mar; 45(3):1122-6. PubMed ID: 2982483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of a requirement for long-range DNA torsional strain in the production of protein-associated DNA strand breaks in isolated mammalian cell nuclei by the DNA intercalating agent 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA).
    Pommier Y; Zwelling LA; Schwartz RE; Mattern MR; Kohn KW
    Biochem Pharmacol; 1984 Dec; 33(23):3909-12. PubMed ID: 6548917
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II clinical trial of 4'-(9-acridinylamino) methanesulphon-m-anisidide (m-AMSA) in the treatment of advanced non-Hodgkin's lymphomas.
    Abate G; Villari P; Comella P; D'Aprile M; Castello G; Silvestro P; Zarrilli D; Pergola M
    Haematologica; 1985; 70(1):35-8. PubMed ID: 3924754
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the in vivo and in vitro antileukemic activity of monosubstituted derivatives of 4'-(9-acridinylamino)methanesulfon-m-anisidide.
    Baguley BC; Cain BF
    Mol Pharmacol; 1982 Sep; 22(2):486-92. PubMed ID: 6897281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of antitumor properties of nitracrine and amsacrine analogs.
    Mazerska Z; Chołody M; Lukowicz J; Wysocka-Skrzela B; Ledóchowski A
    Arzneimittelforschung; 1987 Nov; 37(11):1276-81. PubMed ID: 3326605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomol DNA fragments from mouse cells exposed to an intercalating agent contain a 175-kdalton terminal polypeptide.
    Ralph RK; Hancock R
    Can J Biochem Cell Biol; 1985 Jul; 63(7):780-3. PubMed ID: 3840052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.